Strange new catalyst for gold ($5,000 possible?)

Gold: Now legal tender Most Americans missed this big story, but 1 in 5 states have now made gold and silver coins legal tender. It's just one reason why so many predict gold will soon hit $5,000. And why you need to check out this $6 strategy for gold immediately.

ARQT Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 9.50%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $937,025.90

Arcutis Biotherapeutics Insider Trading History Chart

Arcutis Biotherapeutics Share Price & Price History

^$9.30

▲ +0.58 (6.65%)

As of 11/5/2024 06:38 PM ET

Days: 30 | 90 | 365

NASDAQ traded stock with a BIG short position.

From Huge Alerts | Ad

Small cap NASDAQ firm is an innovative leader in non-opioid pain therapeutics. The company’s offerings could significantly aid in stopping the opioid crisis and create maximum shareholder growth!

See how this NASDAQ Bio-tech is offering viable solutions

Arcutis Biotherapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/2/2024	Larry Todd Edwards	SVP	Sell	3,725	$10.01	$37,287.25	136,635
10/1/2024	Howard G. Welgus	Director	Sell	10,000	$9.26	$92,600.00	181,944
9/24/2024	David Joseph Topper	CFO	Sell	11,626	$9.48	$110,214.48	158,374
9/3/2024	Howard G. Welgus	Director	Sell	10,000	$10.77	$107,700.00	191,944
8/19/2024	Patrick Burnett	Insider	Sell	1,728	$8.29	$14,325.12	194,859
8/2/2024	Masaru Matsuda	Insider	Sell	5,220	$9.02	$47,084.40	183,288
8/1/2024	Howard G. Welgus	Director	Sell	10,000	$9.87	$98,700.00	176,953
7/1/2024	Howard G. Welgus	Director	Sell	10,000	$9.31	$93,100.00	180,339
5/30/2024	Patrick Burnett	Insider	Sell	23,000	$8.75	$201,250.00	209,793
5/28/2024	Masaru Matsuda	Insider	Sell	1,775	$9.01	$15,992.75	188,508
5/17/2024	Larry Todd Edwards	SVP	Sell	7,640	$8.98	$68,607.20	140,360
3/4/2024	Masaru Matsuda	Insider	Sell	3,760	$11.12	$41,811.20	190,424
1/2/2024	Patrick Burnett	Insider	Sell	1,325	$3.54	$4,690.50	57,032
11/21/2023	Masaru Matsuda	Insider	Sell	1,850	$1.98	$3,663.00	46,634
10/24/2023	Life Sciences Viii L Frazier	Major Shareholder	Buy	80,000	$2.50	$200,000.00	8,764,232
8/21/2023	Patrick Burnett	Insider	Sell	1,605	$7.04	$11,299.20	58,357
5/31/2023	Masaru Matsuda	Insider	Sell	1,830	$7.80	$14,274.00	42,146
4/17/2023	Howard G. Welgus	Director	Sell	8,500	$13.97	$118,745.00	165,825
4/6/2023	Howard G. Welgus	Director	Sell	8,500	$12.01	$102,085.00	165,825
3/6/2023	Patricia A. Turney	SVP	Sell	831	$15.26	$12,681.06	62,862
3/6/2023	Scott L. Burrows	CFO	Sell	291	$15.26	$4,440.66	59,115
3/6/2023	Todd Franklin Watanabe	Insider	Sell	2,435	$15.26	$37,158.10	366,657
3/2/2023	Patricia A. Turney	SVP	Sell	1,432	$15.83	$22,668.56	45,693
3/2/2023	Scott L. Burrows	CFO	Sell	1,434	$15.83	$22,700.22	38,406
3/2/2023	Todd Franklin Watanabe	Insider	Sell	5,472	$15.83	$86,621.76	369,092
2/28/2023	Patricia A. Turney	SVP	Sell	936	$16.17	$15,135.12	47,125
2/28/2023	Scott L. Burrows	CFO	Sell	416	$16.17	$6,726.72	39,840
2/28/2023	Todd Franklin Watanabe	Insider	Sell	2,343	$16.17	$37,886.31	374,564
2/15/2023	Howard G. Welgus	Director	Sell	8,500	$16.98	$144,330.00	165,825
2/13/2023	Todd Franklin Watanabe	Insider	Sell	483	$17.00	$8,211.00	377,424
1/17/2023	Howard G. Welgus	Director	Sell	8,500	$13.72	$116,620.00	165,825
1/3/2023	Patrick Burnett	Insider	Sell	1,475	$15.01	$22,139.75	41,564
12/7/2022	Todd Franklin Watanabe	Insider	Sell	1,000	$17.06	$17,060.00	378,907
11/21/2022	Masaru Matsuda	Insider	Sell	1,720	$18.19	$31,286.80	19,535
11/7/2022	Todd Franklin Watanabe	Insider	Sell	1,000	$18.00	$18,000.00	379,907
10/7/2022	Todd Franklin Watanabe	CEO	Sell	1,000	$19.51	$19,510.00	380,907
10/4/2022	Howard G. Welgus	Director	Sell	6,000	$20.29	$121,740.00	168,208
9/7/2022	Todd Franklin Watanabe	CEO	Sell	1,000	$21.51	$21,510.00	381,907
8/15/2022	Howard G. Welgus	Director	Sell	6,000	$24.80	$148,800.00	174,208
7/18/2022	Howard G. Welgus	Director	Sell	6,000	$24.40	$146,400.00	180,208
7/8/2022	David W Osborne	Insider	Sell	2,197	$25.41	$55,825.77	256,649
7/8/2022	Todd Franklin Watanabe	CEO	Sell	13,500	$25.37	$342,495.00	651,871
7/6/2022	Todd Franklin Watanabe	CEO	Sell	1,000	$22.07	$22,070.00	658,284
6/24/2022	Orbimed Advisors Llc	Major Shareholder	Sell	341,971	$21.31	$7,287,402.01	415,142
6/2/2022	Masaru Matsuda	SVP	Sell	1,795	$19.73	$35,415.35	16,380
6/1/2022	Howard G. Welgus	Director	Sell	2,500	$20.62	$51,550.00	181,896
5/5/2022	Todd Franklin Watanabe	CEO	Sell	1,000	$21.76	$21,760.00	658,667
5/2/2022	Howard G. Welgus	Director	Sell	2,500	$20.44	$51,100.00	181,896
4/21/2022	David W Osborne	Insider	Sell	2,197	$20.42	$44,862.74	257,229
4/8/2022	Orbimed Advisors Llc	Major Shareholder	Sell	200,000	$20.71	$4,142,000.00
4/6/2022	Orbimed Advisors Llc	Major Shareholder	Sell	333,204	$20.69	$6,893,990.76
4/5/2022	Todd Franklin Watanabe	CEO	Sell	1,000	$21.43	$21,430.00	659,667
4/1/2022	Howard G. Welgus	Director	Sell	7,500	$20.02	$150,150.00
3/9/2022	Todd Franklin Watanabe	CEO	Sell	300	$17.00	$5,100.00
3/7/2022	Patrick Burnett	Insider	Sell	30	$16.44	$493.20
3/7/2022	Scott L. Burrows	CFO	Sell	10	$16.44	$164.40
3/7/2022	Todd Franklin Watanabe	CEO	Sell	770	$17.05	$13,128.50
3/4/2022	Patricia A. Turney	SVP	Sell	993	$16.86	$16,741.98
3/4/2022	Patrick Burnett	Insider	Sell	981	$16.86	$16,539.66
3/4/2022	Scott L. Burrows	CFO	Sell	293	$16.86	$4,939.98
3/4/2022	Todd Franklin Watanabe	CEO	Sell	2,489	$16.86	$41,964.54
2/9/2022	Todd Franklin Watanabe	CEO	Sell	1,000	$17.00	$17,000.00
1/5/2022	Todd Franklin Watanabe	CEO	Sell	1,000	$21.59	$21,590.00
1/3/2022	Howard G. Welgus	Director	Sell	2,500	$21.21	$53,025.00
12/27/2021	Scott L. Burrows	CFO	Sell	12,560	$20.07	$252,079.20
12/23/2021	Howard G. Welgus	Director	Sell	2,500	$20.16	$50,400.00
12/8/2021	Todd Franklin Watanabe	CEO	Sell	1,000	$17.00	$17,000.00
11/5/2021	Todd Franklin Watanabe	CEO	Sell	1,000	$21.50	$21,500.00

NASDAQ traded stock with a BIG short position.

From Huge Alerts | Ad

Small cap NASDAQ firm is an innovative leader in non-opioid pain therapeutics. The company’s offerings could significantly aid in stopping the opioid crisis and create maximum shareholder growth!

See how this NASDAQ Bio-tech is offering viable solutions

SEC Filings (Institutional Ownership Changes) for Arcutis Biotherapeutics (NASDAQ:ARQT)

Institutional Buying and Selling by Quarter

Arcutis Biotherapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/5/2024	GSA Capital Partners LLP	237,174	$2.21M	0.2%	+730.0%	0.203%
11/4/2024	Los Angeles Capital Management LLC	125,103	$1.16M	0.0%	-8.0%	0.107%
10/25/2024	AMI Asset Management Corp	223,681	$2.08M	0.1%	+36.2%	0.193%
10/25/2024	China Universal Asset Management Co. Ltd.	22,482	$0.21M	0.0%	+65.3%	0.019%
10/25/2024	abrdn plc	482,074	$4.48M	0.0%	+223.8%	0.416%
10/23/2024	Hennion & Walsh Asset Management Inc.	43,968	$0.41M	0.0%	-9.5%	0.038%
10/11/2024	Creative Planning	13,676	$0.13M	0.0%	N/A	0.012%
10/11/2024	Wesbanco Bank Inc.	102,700	$0.96M	0.0%	N/A	0.088%
10/10/2024	Inspire Investing LLC	44,344	$0.41M	0.0%	N/A	0.038%
10/3/2024	SG Americas Securities LLC	38,333	$0.36M	0.0%	-61.3%	0.033%
8/16/2024	Perceptive Advisors LLC	1,558,500	$14.49M	0.3%	+107.8%	1.346%
8/16/2024	Capital Impact Advisors LLC	65,147	$0.61M	1.7%	N/A	0.056%
8/16/2024	Algert Global LLC	10,415	$97K	0.0%	N/A	0.009%
8/15/2024	The Manufacturers Life Insurance Company	40,323	$0.38M	0.0%	+31.0%	0.035%
8/15/2024	Millennium Management LLC	512,696	$4.77M	0.0%	+35.3%	0.443%
8/15/2024	Dark Forest Capital Management LP	27,612	$0.26M	0.0%	+29.9%	0.024%
8/15/2024	AQR Capital Management LLC	257,357	$2.39M	0.0%	+727.5%	0.222%
8/15/2024	Alpha DNA Investment Management LLC	52,244	$0.49M	0.2%	N/A	0.045%
8/14/2024	Farallon Capital Management LLC	26,000	$0.24M	0.0%	-98.5%	0.022%
8/14/2024	ProShare Advisors LLC	17,739	$0.17M	0.0%	-15.5%	0.015%
8/14/2024	Profund Advisors LLC	48,190	$0.45M	0.0%	-61.8%	0.042%
8/13/2024	Rubric Capital Management LP	9,816,672	$91.30M	2.4%	+30.7%	8.480%
8/13/2024	Ensign Peak Advisors Inc	2,133,702	$19.84M	0.0%	-28.4%	1.843%
8/12/2024	XTX Topco Ltd	36,466	$0.34M	0.0%	+241.7%	0.032%
8/12/2024	Hsbc Holdings PLC	14,099	$0.13M	0.0%	-97.2%	0.012%
8/12/2024	E Fund Management Co. Ltd.	15,759	$0.15M	0.0%	-59.5%	0.014%
8/8/2024	American Century Companies Inc.	1,231,700	$11.46M	0.0%	+18.3%	1.064%
8/6/2024	Acadian Asset Management LLC	160,028	$1.49M	0.0%	N/A	0.138%
8/6/2024	Los Angeles Capital Management LLC	135,948	$1.26M	0.0%	-8.4%	0.117%
8/6/2024	Candriam S.C.A.	1,307,481	$12.16M	0.1%	N/A	1.129%
8/5/2024	Arizona State Retirement System	28,968	$0.27M	0.0%	N/A	0.025%
8/1/2024	Rhumbline Advisers	167,289	$1.56M	0.0%	+33.5%	0.145%
7/29/2024	Zurcher Kantonalbank Zurich Cantonalbank	18,762	$0.17M	0.0%	N/A	0.016%
7/26/2024	Legato Capital Management LLC	56,208	$0.52M	0.1%	N/A	0.049%
7/26/2024	Bank of New York Mellon Corp	390,202	$3.63M	0.0%	+25.8%	0.337%
7/25/2024	AMI Asset Management Corp	164,194	$1.53M	0.1%	-52.4%	0.142%
7/12/2024	SG Americas Securities LLC	99,161	$0.92M	0.0%	+531.2%	0.086%
7/10/2024	CWM LLC	4,104	$38K	0.0%	+6,740.0%	0.004%
5/24/2024	Farallon Capital Management LLC	1,780,000	$17.64M	0.1%	N/A	1.538%
5/17/2024	Ikarian Capital LLC	589,642	$5.84M	0.6%	N/A	0.510%
5/16/2024	California State Teachers Retirement System	7,956	$79K	0.0%	-38.9%	0.007%
5/16/2024	Bain Capital Life Sciences Investors LLC	2,011,687	$19.94M	1.6%	-32.9%	1.741%
5/15/2024	Price T Rowe Associates Inc. MD	47,753	$0.47M	0.0%	+3.6%	0.041%
5/15/2024	PEAK6 Investments LLC	30,000	$0.30M	0.0%	+50.0%	0.026%
5/13/2024	Ameritas Investment Partners Inc.	7,871	$78K	0.0%	+55.2%	0.007%
5/10/2024	Vanguard Group Inc.	5,166,417	$51.20M	0.0%	+5.5%	4.472%
5/9/2024	State Board of Administration of Florida Retirement System	13,787	$0.15M	0.0%	-32.9%	0.012%
5/9/2024	Koshinski Asset Management Inc.	20,000	$0.20M	0.0%	N/A	0.017%
5/8/2024	ProShare Advisors LLC	20,990	$0.21M	0.0%	+9.8%	0.018%
5/7/2024	Susquehanna Fundamental Investments LLC	120,493	$1.19M	0.1%	N/A	0.104%
5/7/2024	SG Americas Securities LLC	15,709	$0.16M	0.0%	-35.5%	0.014%
5/2/2024	Jennison Associates LLC	12,176,315	$120.67M	0.1%	+34.3%	10.540%
5/1/2024	Capstone Investment Advisors LLC	57,378	$0.57M	0.0%	N/A	0.050%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	46,654	$0.47M	0.0%	N/A	0.040%
4/29/2024	China Universal Asset Management Co. Ltd.	18,614	$0.18M	0.0%	+70.5%	0.016%
4/23/2024	Fishman Jay A Ltd. MI	224,300	$2.22M	0.2%	+323.2%	0.232%
4/19/2024	AMI Asset Management Corp	345,239	$3.42M	0.2%	N/A	0.357%
4/17/2024	Hennion & Walsh Asset Management Inc.	48,997	$0.49M	0.0%	+14.4%	0.051%
4/5/2024	Los Angeles Capital Management LLC	148,433	$1.47M	0.0%	-23.7%	0.153%
2/15/2024	Opaleye Management Inc.	1,960,000	$6.33M	1.7%	N/A	2.077%
2/15/2024	Frazier Life Sciences Management L.P.	8,764,232	$28.31M	1.5%	+0.9%	9.286%
2/15/2024	Cantor Fitzgerald L. P.	10,114	$33K	0.0%	N/A	0.011%
2/14/2024	ADAR1 Capital Management LLC	275,000	$0.89M	0.3%	N/A	0.291%
2/14/2024	Pennant Investors LP	170,900	$0.55M	0.1%	N/A	0.181%
2/14/2024	Ghisallo Capital Management LLC	100,000	$0.32M	0.0%	N/A	0.106%
2/14/2024	Pivotal bioVenture Partners Investment Advisor LLC	1,910,009	$6.17M	1.6%	+72.8%	2.024%
2/14/2024	Rubric Capital Management LP	6,644,530	$21.46M	0.4%	+32.0%	7.040%
2/14/2024	Vestal Point Capital LP	2,700,000	$8.72M	0.9%	N/A	2.861%
2/12/2024	Cape Investment Advisory Inc.	8,004	$26K	0.0%	N/A	0.008%
2/9/2024	Franklin Resources Inc.	4,655,544	$15.04M	0.0%	+260.2%	4.933%
2/9/2024	GW&K Investment Management LLC	1,640,325	$5.30M	0.0%	-20.7%	1.738%
2/8/2024	Wade G W & Inc.	53,100	$0.17M	0.0%	+34.8%	0.056%
2/6/2024	Amalgamated Bank	11,078	$36K	0.0%	+48.9%	0.012%
2/6/2024	Los Angeles Capital Management LLC	194,461	$0.63M	0.0%	N/A	0.206%
2/6/2024	Wilbanks Smith & Thomas Asset Management LLC	20,000	$65K	0.0%	N/A	0.021%
2/5/2024	Victory Capital Management Inc.	10,419	$34K	0.0%	N/A	0.011%
2/1/2024	Jennison Associates LLC	9,066,082	$29.28M	0.0%	+104.6%	9.606%
1/31/2024	abrdn plc	148,874	$0.48M	0.0%	N/A	0.158%
1/31/2024	Federated Hermes Inc.	521,469	$1.68M	0.0%	+769.1%	0.553%
1/30/2024	Vontobel Holding Ltd.	21,000	$68K	0.0%	-57.3%	0.022%
1/24/2024	DekaBank Deutsche Girozentrale	140,000	$0.46M	0.0%	N/A	0.148%
1/24/2024	Fishman Jay A Ltd. MI	53,000	$0.17M	0.0%	-39.1%	0.056%
1/24/2024	China Universal Asset Management Co. Ltd.	10,920	$35K	0.0%	+586.8%	0.012%
1/12/2024	SG Americas Securities LLC	24,356	$79K	0.0%	N/A	0.026%
1/1/2024	Deutsche Bank AG	30,362	$0.16M	0.0%	+13.7%	0.032%
12/6/2023	Citigroup Inc.	176,822	$0.94M	0.0%	+15.1%	0.187%
11/22/2023	Polar Capital Holdings Plc	3,117,944	$16.56M	0.1%	-0.3%	3.304%
11/15/2023	Tejara Capital Ltd	309,179	$1.64M	0.9%	+88.3%	0.328%
11/15/2023	Rubric Capital Management LP	5,034,530	$26.73M	1.0%	+3.1%	5.334%
11/14/2023	Rubric Capital Management LP	5,034,530	$26.73M	1.0%	+3.1%	5.334%
11/14/2023	Trexquant Investment LP	58,568	$0.31M	0.0%	N/A	0.062%
11/14/2023	Profund Advisors LLC	69,926	$0.37M	0.0%	-22.1%	0.074%
11/13/2023	Fishman Jay A Ltd. MI	87,000	$0.46M	0.1%	+13.0%	0.092%
11/13/2023	Federated Hermes Inc.	60,000	$0.32M	0.0%	+50.0%	0.064%
11/13/2023	Dark Forest Capital Management LP	74,293	$0.39M	0.0%	N/A	0.079%
11/13/2023	FMR LLC	8,262,042	$43.87M	0.0%	-10.3%	8.754%
11/13/2023	Tejara Capital Ltd	309,179	$1.64M	1.2%	+88.3%	0.328%
11/13/2023	Rafferty Asset Management LLC	419,309	$2.23M	0.0%	-16.1%	0.444%
11/13/2023	E Fund Management Co. Ltd.	21,535	$0.11M	0.0%	-19.9%	0.023%
11/9/2023	Citigroup Inc.	176,822	$0.94M	0.0%	+15.1%	0.287%

Data available starting January 2016

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical ZORYVE for the treatment of scalp and body psoriasis and seborrheic dermatitis; ARQ-252, a selective topical janus kinase type 1 inhibitor for hand eczema and vitiligo; ARQ-255, a topical JAK1 inhibitor for alopecia areata; and ARQ-234, a CD200R fusion protein for the treatment of moderate-to-severe atopic dermatitis. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.

Today's Range

Now: $9.30

$8.45

$9.33

50 Day Range

MA: $9.73

$8.31

$11.00

52 Week Range

Now: $9.30

$1.76

$13.17

Volume

2,583,746 shs

Average Volume

3,248,305 shs

Market Capitalization

$1.09 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.18

Who are the company insiders with the largest holdings of Arcutis Biotherapeutics?: Arcutis Biotherapeutics' top insider shareholders include:
Life Sciences Viii L Frazier (Major Shareholder)
Todd Franklin Watanabe (Insider)
Patrick Burnett (Insider)
Howard G Welgus (Director)
Masaru Matsuda (Insider)
David Joseph Topper (CFO)
Larry Todd Edwards (SVP)
Patricia A Turney (SVP)
Scott L Burrows (CFO)
Learn More about top insider investors at Arcutis Biotherapeutics.
Who are the major institutional investors of Arcutis Biotherapeutics?: Arcutis Biotherapeutics' top institutional shareholders include:
abrdn plc — 0.42%
GSA Capital Partners LLP — 0.20%
AMI Asset Management Corp — 0.19%
Los Angeles Capital Management LLC — 0.11%
Wesbanco Bank Inc. — 0.09%
Inspire Investing LLC — 0.04%
Learn More about top institutional investors of Arcutis Biotherapeutics stock.
Which institutional investors are selling Arcutis Biotherapeutics stock?: During the previous quarter, ARQT stock was sold by these institutional investors:
SG Americas Securities LLC
Los Angeles Capital Management LLC
Hennion & Walsh Asset Management Inc.
In the last year, company insiders that have sold Arcutis Biotherapeutics company stock include:
Life Sciences Viii L Frazier (Major Shareholder)
Todd Franklin Watanabe (Insider)
Patrick Burnett (Insider)
Howard G Welgus (Director)
Masaru Matsuda (Insider)
Learn More investors selling Arcutis Biotherapeutics stock.
Which institutional investors are buying Arcutis Biotherapeutics stock?: During the previous quarter, ARQT stock was purchased by institutional investors including:
abrdn plc
GSA Capital Partners LLP
Wesbanco Bank Inc.
AMI Asset Management Corp
Inspire Investing LLC
Creative Planning
China Universal Asset Management Co. Ltd.